MENU
+Compare
CADL
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$5.54
Change
+$0.27 (+5.12%)
Capitalization
304.12M

CADL Candel Therapeutics Forecast, Technical & Fundamental Analysis

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more

CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CADL with price predictions
Sep 25, 2025

CADL's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for CADL moved out of oversold territory on September 15, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In of the 21 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2025. You may want to consider a long position or call options on CADL as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CADL just turned positive on September 22, 2025. Looking at past instances where CADL's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CADL advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

CADL moved below its 50-day moving average on August 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CADL crossed bearishly below the 50-day moving average on August 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CADL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CADL broke above its upper Bollinger Band on September 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CADL entered a downward trend on September 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CADL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.372) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (344.769).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CADL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CADL is expected to report earnings to rise 99.22% to -17 cents per share on November 06

Candel Therapeutics CADL Stock Earnings Reports
Q3'25
Est.
$-0.18
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.50
Q4'24
Missed
by $0.10
Q4'23
Missed
by $0.20
The last earnings report on August 14 showed earnings per share of -9 cents, beating the estimate of -15 cents. With 729.00K shares outstanding, the current market capitalization sits at 304.12M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDNTF185.17N/A
N/A
Canadian Tire Corp. Ltd.
GLNCY8.86N/A
N/A
Glencore Plc
PXCLF0.04N/A
N/A
Phoenix Copper Limited
CMRB4.86N/A
N/A
First Commerce Bancorp Inc.
HKBNF0.40N/A
N/A
HKBN Ltd

CADL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RPTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+5.31%
RPTX - CADL
44%
Loosely correlated
+1.20%
INKT - CADL
34%
Loosely correlated
+2.65%
INO - CADL
33%
Poorly correlated
+1.69%
CELC - CADL
32%
Poorly correlated
-2.58%
MRNA - CADL
31%
Poorly correlated
-0.45%
More